ABMD
Price:
$381.02
Market Cap:
$17.18B
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flo...[Read more]
Industry
Medical - Devices
IPO Date
1987-07-29
Stock Exchange
NASDAQ
Ticker
ABMD
According to Abiomed, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 17.05B. This represents a change of 28.15% compared to the average of 13.30B of the last 4 quarters.
The mean historical Enterprise Value of Abiomed, Inc. over the last ten years is 7.45B. The current 17.05B Enterprise Value has changed 22.77% with respect to the historical average. Over the past ten years (40 quarters), ABMD's Enterprise Value was at its highest in in the September 2018 quarter at 19.90B. The Enterprise Value was at its lowest in in the December 2012 quarter at 519.01M.
Average
7.45B
Median
5.88B
Minimum
706.32M
Maximum
14.92B
Discovering the peaks and valleys of Abiomed, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 187.64%
Maximum Annual Enterprise Value = 14.92B
Minimum Annual Increase = -48.47%
Minimum Annual Enterprise Value = 706.32M
Year | Enterprise Value | Change |
---|---|---|
2022 | 14.92B | 5.41% |
2021 | 14.15B | 122.35% |
2020 | 6.37B | -48.47% |
2019 | 12.35B | -3.53% |
2018 | 12.81B | 137.54% |
2017 | 5.39B | 36.37% |
2016 | 3.95B | 36.97% |
2015 | 2.89B | 187.64% |
2014 | 1.00B | 42.05% |
2013 | 706.32M | -16.46% |
The current Enterprise Value of Abiomed, Inc. (ABMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
11.81B
5-year avg
12.12B
10-year avg
7.45B
Abiomed, Inc.’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abiomed, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Abiomed, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Abiomed, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Abiomed, Inc. (ABMD)?
What is the 3-year average Enterprise Value for Abiomed, Inc. (ABMD)?
What is the 5-year average Enterprise Value for Abiomed, Inc. (ABMD)?
How does the current Enterprise Value for Abiomed, Inc. (ABMD) compare to its historical average?